Revive Therapeutics

Revive Therapeutics RVVTF Stock

$0.01   -29.999996%
Add to favorites
Market Cap
$3.11M
LOW - HIGH [24H]
$0.01 - $0.01
VOLUME [24H]
$179.50K
P/E Ratio
0
Earnings per share
$0.00
ISIN
CA7615161030

Revive Therapeutics Price Chart

Sorry, that's all we've gotfor now...

Revive Therapeutics (RVVTF) stock price today is 0.0070 USD on OTC Markets OTCPK (-30% on the day). Updated .

Revive Therapeutics RVVTF Financial and Trading Overview

Revive Therapeutics stock price 0.0070 USD
Previous Close 0.01 USD
Open 0.0076 USD
Bid 0.0051 USD x 1000000
Ask 0.0072 USD x 1000000
Day's Range 0.0064 - 0.0076 USD
52 Week Range 0.002 - 0.06 USD
Volume 179.5K USD
Avg. Volume 192.13K USD
Market Cap 3.11M USD
Beta (5Y Monthly) -1.821
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est N/A

RVVTF Valuation Measures

Enterprise Value 3.06M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.874

Trading Information

Revive Therapeutics Stock Price History

Beta (5Y Monthly) -1.821
52-Week Change -22.22%
S&P500 52-Week Change 3.06%
52 Week High 0.06 USD
52 Week Low 0.002 USD
50-Day Moving Average 0.02 USD
200-Day Moving Average 0.02 USD

RVVTF Share Statistics

Avg. Volume (3 month) 192.13K USD
Avg. Daily Volume (10-Days) 336.05K USD
Shares Outstanding 444.61M
Float 438.29M
Short Ratio N/A
% Held by Insiders 1.45%
% Held by Institutions 0.0020%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2026
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End June 30, 2027

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -272.83%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -1065815 USD
Net Income Avi to Common (ttm) -1023650 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 4.83K USD
Total Cash Per Share (mrq) 0 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.036
Book Value Per Share (mrq) -0.00640872

Cash Flow Statement

Operating Cash Flow (ttm) -158528 USD
Levered Free Cash Flow (ttm) 191.8K USD

Profile of Revive Therapeutics

Country United States
State ON
City Toronto
Address The Canadian Venture Building
ZIP M5C 1P1
Phone 888-901-0036
Website https://revivethera.com
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees N/A

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. The company develops Bucillamine-based therapies, psilocybin-based therapeutics, and Long COVID diagnostics, as well as commercializes delivery technologies for psychedelics and cannabinoids. Revive Therapeutics Ltd. was founded in 2012 and is based in Toronto, Canada.

Q&A For Revive Therapeutics Stock

What is a current RVVTF stock price?

Revive Therapeutics RVVTF stock price today per share is 0.0070 USD.

How to purchase Revive Therapeutics stock?

You can buy RVVTF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Revive Therapeutics?

The stock symbol or ticker of Revive Therapeutics is RVVTF.

Which industry does the Revive Therapeutics company belong to?

The Revive Therapeutics industry is Drug Manufacturers - Specialty & Generic.

How many shares does Revive Therapeutics have in circulation?

The max supply of Revive Therapeutics shares is 444.61M.

What is Revive Therapeutics Price to Earnings Ratio (PE Ratio)?

Revive Therapeutics PE Ratio is now.

What was Revive Therapeutics earnings per share over the trailing 12 months (TTM)?

Revive Therapeutics EPS is 0 USD over the trailing 12 months.

Which sector does the Revive Therapeutics company belong to?

The Revive Therapeutics sector is Healthcare.

$2.06T
Total marketcap
$71.16B
Total volume
BTC 58.82%   •   ETH 10.04%
Dominance
Select currency